Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Argan (AGX) EBT (2016 - 2026)

Argan (AGX) has disclosed EBT for 17 consecutive years, with $42.6 million as the latest value for Q1 2026.

  • Quarterly EBT rose 161.6% to $42.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $147.7 million through Jan 2026, up 4173.41% year-over-year, with the annual reading at $147.7 million for FY2026, 4173.41% up from the prior year.
  • EBT hit $42.6 million in Q1 2026 for Argan, up from $39.7 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $42.6 million in Q1 2026 to a low of -$69.1 million in Q1 2025.
  • Historically, EBT has averaged $14.5 million across 5 years, with a median of $13.9 million in 2022.
  • Biggest five-year swings in EBT: soared 6266.67% in 2023 and later crashed 507.12% in 2025.
  • Year by year, EBT stood at $10.3 million in 2022, then grew by 12.46% to $11.6 million in 2023, then skyrocketed by 218.97% to $37.0 million in 2024, then grew by 7.34% to $39.7 million in 2025, then grew by 7.25% to $42.6 million in 2026.
  • Business Quant data shows EBT for AGX at $42.6 million in Q1 2026, $39.7 million in Q4 2025, and $35.6 million in Q3 2025.